DARA Biosciences (DARA +8.5%) pops after signing an exclusive agreement with Uman Pharma for U.S. commercialization rights to its newly licensed anticancer-agent gemcitabine.
DARA Biosciences (DARA +8.5%) pops after signing an exclusive agreement with Uman Pharma for...
Recommended For You
More Trending News
About BDRX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BDRX | - | - |
| Biodexa Pharmaceuticals Plc | ||